High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$10.5M
$10,479,648
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| TVTX |
Travere Therapeutics, Inc.
|
CEO
Other
|
2026-02-20 | $927,600 | M | Form 4 |
|
TVTX
S
Travere Therapeutics, Inc.
Dube Eric M
• CEO
10b5-1 SellΔOwn -12.2%
2026-02-20
$1,805,766Large
|
||||||
| TVTX |
Travere Therapeutics, Inc.
|
CEO
10b5-1 SellΔOwn -12.2%
|
2026-02-20 | $1,805,766Large | S | Form 4 |
| TVTX |
Travere Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-03 | $3,230,316Largex2 | S | Form 4 |
| TVTX |
Travere Therapeutics, Inc.
|
CEO
Other
|
2026-01-27 | $801,833 | M | Form 4 |
|
TVTX
S
Travere Therapeutics, Inc.
Dube Eric M
• CEO
10b5-1 SellΔOwn -11.0%
2026-01-27
$1,560,981Large
|
||||||
| TVTX |
Travere Therapeutics, Inc.
|
CEO
10b5-1 SellΔOwn -11.0%
|
2026-01-27 | $1,560,981Large | S | Form 4 |
| TVTX |
Travere Therapeutics, Inc.
|
CEO
Other
|
2026-01-23 | $125,767 | M | Form 4 |
| TVTX |
Travere Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-23 | $244,153 | S | Form 4 |
| TVTX |
Travere Therapeutics, Inc.
|
CEO
Other
|
2025-10-29 | $419,399 | M | Form 4 |
| TVTX |
Travere Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-29 | $817,074 | S | Form 4 |
| TVTX |
Travere Therapeutics, Inc.
|
CEO
Other
|
2025-10-28 | $1,435,801Large | M | Form 4 |
|
TVTX
S
Travere Therapeutics, Inc.
Dube Eric M
• CEO
10b5-1 SellΔOwn -18.1%
2025-10-28
$2,821,358Large
|
||||||
| TVTX |
Travere Therapeutics, Inc.
|
CEO
10b5-1 SellΔOwn -18.1%
|
2025-10-28 | $2,821,358Large | S | Form 4 |